Categories Earnings Calls, Health Care

Johnson & Johnson (JNJ) Q2 2021 Earnings Call

Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021

Corporate Participants:

Christopher DelOrefice — Vice President, Investor Relations

Joseph J. Wolk — Executive Vice President, Chief Financial Officer

Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals

Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health

Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices

Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer

Analysts:

Louise Chen — Cantor Fitzgerald Securities — Analyst

Larry Biegelsen — Wells Fargo Securities LLC — Analyst

Chris Schott — J.P. Morgan Securities LLC — Analyst

Bob Hopkins — BofA Securities, Inc. — Analyst

Joshua Jennings — Cowen and Company — Analyst

Terence Flynn — Goldman Sachs & Co. LLC — Analyst

Matt Miksic — Credit Suisse Securities (USA) LLC — Analyst

Joanne Wuensch — Citi — Analyst

Jayson Bedford — Raymond James Financial Inc. — Analyst

_________

To read the full earnings call transcript, click here

Most Popular

Redfin (RDFN) Stock: Here’s a look at the factors to consider before investing

It is estimated that the U.S. real estate industry would expand at a compound annual rate of 7% through 2026, catalyzed by the growing adoption of automation in property management

IPO news: What to look for when Four Springs Capital goes public this week

A slew of companies have lined up for their IPOs this week. Four Springs Capital Trust, a self-managed REIT, is one of them. Here’s what to look for when this

Charles Schwab (SCHW) Q4 revenue up 13%; earnings miss estimates

Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Tuesday reported higher earnings and revenues for the fourth quarter of 2021. However, the numbers missed Wall Street’s forecast, and

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top